Table 1 Clinicopathological characteristics of the patients with HIV-associated lung cancer.
Clinicopathological characteristic | No. of Patients | Overall Survival | |
|---|---|---|---|
n | Months ± SD | P value | |
Age (years) | 0.915 | ||
<60 | 37 | 13.86 ± 1.81 | |
≥60 | 22 | 14.57 ± 3.78 | |
Gender | 0.194 | ||
Male | 52 | 13.10 ± 1.58 | |
Female | 7 | 21.43 ± 9.24 | |
Smoking* | 0.479 | ||
+ | 30 | 1317 ± 2.17 | |
− | 29 | 15.11 ± 2.87 | |
HAART | 0.619 | ||
+ | 39 | 15.03 ± 2.26 | |
− | 20 | 12.17 ± 2.85 | |
Complication & | 0.209 | ||
+ | 20 | 17.50 ± 4.29 | |
− | 29 | 12.34 ± 1.71 | |
CD4+ count | 0.324 | ||
<200 | 14 | 11.46 ± 2.72 | |
>200 | 41 | 15.70 ± 2.34 | |
Lung cancer | 0.921 | ||
NSCLC | 50 | 13.83 ± 1.64 | |
SCLC | 9 | 15.00 ± 8.42 | |
Pathological type | 0.717 | ||
AC | 36 | 14.83 ± 2.08 | |
SCC | 14 | 11.15 ± 2.29 | |
SCLC | 9 | 15.00 ± 8.42 | |
TMN stage | 0.026 | ||
I-II | 30 | 17.66 ± 2.88 | |
III-IV | 29 | 10.46 ± 1.87 | |
